Bespoke Extracts (BSPK) Interest Coverage Ratio (2014 - 2025)
Bespoke Extracts (BSPK) reported Interest Coverage Ratio of 2.23 for Q3 2025, up 88.85% on a YoY basis from 1.18 in Q3 2024, and up 6.49% sequentially from 2.38 in Q2 2025.
Bespoke Extracts (BSPK) Interest Coverage Ratio (2014 - 2025) Analysis & Trends
Bespoke Extracts (BSPK) has 12 years of Interest Coverage Ratio data on file, last reported at 2.23 in Q3 2025.
- For the quarter ending Q3 2025, Interest Coverage Ratio rose 88.85% year-over-year to 2.23; the trailing twelve-month figure through Sep 2025 stood at 3.04 (up 88.93% YoY), and the FY2024 full-year result was 0.52, up 39.07% from the prior year.
- Interest Coverage Ratio grew to 2.23 in Q3 2025, from 2.38 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 2.48 in Q3 2021 to a low of 63.48 in Q4 2023.
- A 5-year average of 12.28 and a median of 4.66 in 2023 frame the typical range for Interest Coverage Ratio.
- Across the five-year window, Interest Coverage Ratio plunged 2871.64% in 2023 and surged 98.26% in 2024, its largest moves.
- Tracing BSPK's Interest Coverage Ratio over 5 years: stood at 2.48 in 2021, then plunged by 185.99% to 2.14 in 2022, then sank by 2871.64% to 63.48 in 2023, then surged by 98.26% to 1.1 in 2024, then slumped by 101.95% to 2.23 in 2025.
- Business Quant data shows BSPK's Interest Coverage Ratio at 2.23 in Q3 2025, 2.38 in Q2 2025, and 3.07 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 13.44 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -2.81 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 0.18 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -0.07 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 0.33 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 5.11 |
| 10 | Bespoke Extracts | 1.12 Mn | 1.11 Mn | 234,175.00 | -2.23 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -2.23 |
| Jun 30, 2025 | -2.38 |
| Mar 31, 2025 | -3.07 |
| Dec 31, 2024 | -1.10 |
| Sep 30, 2024 | -19.97 |
| Jun 30, 2024 | -23.49 |
| Mar 31, 2024 | -26.76 |
| Dec 31, 2023 | -63.48 |
| Sep 30, 2023 | -3.73 |
| Jun 30, 2023 | -12.37 |
| Mar 31, 2023 | -5.59 |
| Dec 31, 2022 | -2.14 |
| Sep 30, 2022 | -16.73 |
| Jun 30, 2022 | -3.14 |
| Mar 31, 2022 | -12.81 |
| Aug 31, 2021 | 2.48 |
| May 31, 2020 | -13.26 |
| Feb 29, 2020 | -1.15 |
| Nov 30, 2019 | -22.34 |
| Aug 31, 2019 | -318,627.00 |